FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2549273821> ?p ?o ?g. }

• W2549273821 abstract "Effective therapies for transitional cell carcinoma (TCC) are limited, with objective response rates to most chemotherapeutic regimens below 20%. The purpose of this study was to investigate the biologic activity of combined toceranib phosphate and vinblastine chemotherapy for treatment of TCC. A secondary objective was to compare the utility of Computed Tomography (CT) and abdominal ultrasound (AUS) in tumor response assessments.Dogs with TCC received vinblastine at 1.6 mg/m2 every 2 weeks and toceranib at 2.5-2.75 mg/kg on Monday/Wednesday/Friday. Tumor monitoring was achieved through CT and AUS. Five patients completed the 16-week study. Based on AUS assessments, 3 dogs experienced biologic response to therapy including partial responses (PR, n = 2) and stable disease (SD, n = 1). Based on CT, 5 dogs experienced a biologic response (n = 2 PR, n = 3 SD). Both imaging modalities (ultrasound and CT) were found to provide repeatable measurements between operators, however agreement between operator measurements was greater when CT images were used to assess tumor size.The combination of toceranib and vinblastine did not result in improved response rates. While agreement in tumor volume assessments between both AUS and CT were excellent between operators, this did not extend to assessment of tumor response. The higher rate of concordance between operators when assessing response to treatment with CT suggests that CT should be considered for future clinical trials involving canine bladder TCC to improve the accuracy and repeatability of tumor measurement. The data suggest that response to therapy as assessed by AUS or CT do not predict duration of clinical response." @default.
• W2549273821 created "2016-11-30" @default.
• W2549273821 creator A5008348897 @default.
• W2549273821 creator A5016151359 @default.
• W2549273821 creator A5016385076 @default.
• W2549273821 creator A5021474295 @default.
• W2549273821 creator A5022150928 @default.
• W2549273821 creator A5025462437 @default.
• W2549273821 creator A5043677957 @default.
• W2549273821 creator A5049737965 @default.
• W2549273821 creator A5050909584 @default.
• W2549273821 creator A5058670846 @default.
• W2549273821 creator A5087167240 @default.
• W2549273821 date "2016-11-17" @default.
• W2549273821 modified "2023-10-01" @default.
• W2549273821 title "A pilot study of toceranib/vinblastine therapy for canine transitional cell carcinoma" @default.
• W2549273821 cites W1527747488 @default.
• W2549273821 cites W1569361914 @default.
• W2549273821 cites W1873903910 @default.
• W2549273821 cites W1899590409 @default.
• W2549273821 cites W1947046122 @default.
• W2549273821 cites W1964525391 @default.
• W2549273821 cites W1966825260 @default.
• W2549273821 cites W1981747359 @default.
• W2549273821 cites W1984446272 @default.
• W2549273821 cites W1986616957 @default.
• W2549273821 cites W1990977566 @default.
• W2549273821 cites W1998028824 @default.
• W2549273821 cites W2000690599 @default.
• W2549273821 cites W2004167719 @default.
• W2549273821 cites W2006091738 @default.
• W2549273821 cites W2006119682 @default.
• W2549273821 cites W2007326663 @default.
• W2549273821 cites W2015795623 @default.
• W2549273821 cites W2016395729 @default.
• W2549273821 cites W2019321720 @default.
• W2549273821 cites W2019607817 @default.
• W2549273821 cites W2026013761 @default.
• W2549273821 cites W2041981723 @default.
• W2549273821 cites W2047023073 @default.
• W2549273821 cites W2049500294 @default.
• W2549273821 cites W2051577701 @default.
• W2549273821 cites W2053644434 @default.
• W2549273821 cites W2055634037 @default.
• W2549273821 cites W2072776458 @default.
• W2549273821 cites W2084562362 @default.
• W2549273821 cites W2096975615 @default.
• W2549273821 cites W2100838274 @default.
• W2549273821 cites W2120735723 @default.
• W2549273821 cites W2123732584 @default.
• W2549273821 cites W2138609461 @default.
• W2549273821 cites W2148968400 @default.
• W2549273821 cites W2154317255 @default.
• W2549273821 cites W2158629604 @default.
• W2549273821 cites W2163046805 @default.
• W2549273821 cites W2166548265 @default.
• W2549273821 cites W2167534619 @default.
• W2549273821 cites W2169963604 @default.
• W2549273821 cites W2177000205 @default.
• W2549273821 cites W2179464188 @default.
• W2549273821 cites W2184765553 @default.
• W2549273821 cites W2195692730 @default.
• W2549273821 cites W2269728304 @default.
• W2549273821 cites W2338139126 @default.
• W2549273821 cites W2410667486 @default.
• W2549273821 cites W2415875989 @default.
• W2549273821 cites W4205388838 @default.
• W2549273821 cites W4249710322 @default.
• W2549273821 cites W4251638272 @default.
• W2549273821 doi "https://doi.org/10.1186/s12917-016-0882-6" @default.
• W2549273821 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5114733" @default.
• W2549273821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27855679" @default.
• W2549273821 hasPublicationYear "2016" @default.
• W2549273821 type Work @default.
• W2549273821 sameAs 2549273821 @default.
• W2549273821 citedByCount "22" @default.
• W2549273821 countsByYear W25492738212016 @default.
• W2549273821 countsByYear W25492738212017 @default.
• W2549273821 countsByYear W25492738212018 @default.
• W2549273821 countsByYear W25492738212019 @default.
• W2549273821 countsByYear W25492738212020 @default.
• W2549273821 countsByYear W25492738212021 @default.
• W2549273821 countsByYear W25492738212022 @default.
• W2549273821 countsByYear W25492738212023 @default.
• W2549273821 crossrefType "journal-article" @default.
• W2549273821 hasAuthorship W2549273821A5008348897 @default.
• W2549273821 hasAuthorship W2549273821A5016151359 @default.
• W2549273821 hasAuthorship W2549273821A5016385076 @default.
• W2549273821 hasAuthorship W2549273821A5021474295 @default.
• W2549273821 hasAuthorship W2549273821A5022150928 @default.
• W2549273821 hasAuthorship W2549273821A5025462437 @default.
• W2549273821 hasAuthorship W2549273821A5043677957 @default.
• W2549273821 hasAuthorship W2549273821A5049737965 @default.
• W2549273821 hasAuthorship W2549273821A5050909584 @default.
• W2549273821 hasAuthorship W2549273821A5058670846 @default.
• W2549273821 hasAuthorship W2549273821A5087167240 @default.
• W2549273821 hasBestOaLocation W25492738211 @default.
• W2549273821 hasConcept C121608353 @default.
• W2549273821 hasConcept C126322002 @default.
• W2549273821 hasConcept C126838900 @default.

• next